Index by author
Patel, S.H.
- Adult BrainYou have accessExtent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular SubtypeS.H. Patel, A.G. Bansal, E.B. Young, P.P. Batchala, J.T. Patrie, M.B. Lopes, R. Jain, C.E. Fadul and D. SchiffAmerican Journal of Neuroradiology July 2019, 40 (7) 1149-1155; DOI: https://doi.org/10.3174/ajnr.A6102
Patrie, J.T.
- Adult BrainYou have accessExtent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular SubtypeS.H. Patel, A.G. Bansal, E.B. Young, P.P. Batchala, J.T. Patrie, M.B. Lopes, R. Jain, C.E. Fadul and D. SchiffAmerican Journal of Neuroradiology July 2019, 40 (7) 1149-1155; DOI: https://doi.org/10.3174/ajnr.A6102
Pereira, V.M.
- EDITOR'S CHOICEPediatricsYou have accessPredictive Value of MRI in Diagnosing Brain AVM Recurrence after Angiographically Documented Exclusion in ChildrenA. Jhaveri, A. Amirabadi, P. Dirks, A.V. Kulkarni, M.M. Shroff, N. Shkumat, T. Krings, V.M. Pereira, V. Rea and P. MuthusamiAmerican Journal of Neuroradiology July 2019, 40 (7) 1227-1235; DOI: https://doi.org/10.3174/ajnr.A6093
The authors sought to determine the predictive values of contrast-enhanced MR imaging and TOF-MRA for brain AVM recurrence in children, compared with conventional angiography, in 39 patients (mean 10.8 years of age, mean Spetzler-Martin grade, 1.9). Features predictive of recurrence included a tuft of vessels on TOF-MRA and nodular juxtamural/linear enhancement with a draining vein on contrast-enhanced MR imaging. MR imaging is useful for surveillance after brain AVM treatment in children, but conventional angiography is required for definitive diagnosis of recurrence. TOF-MRA and contrast-enhanced MR imaging provide complementary information for determining brain AVM recurrence and should be interpreted in conjunction.
Perrini, P.
- NeurointerventionYou have accessAntiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-AnalysisF. Cagnazzo, I. Derraz, P.-H. Lefevre, G. Gascou, C. Dargazanli, C. Riquelme, P. Perrini, D. di Carlo, A. Bonafe and V. CostalatAmerican Journal of Neuroradiology July 2019, 40 (7) 1201-1206; DOI: https://doi.org/10.3174/ajnr.A6086
Prah, M.A.
- Adult BrainOpen AccessQuantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor TrialK.M. Schmainda, M.A. Prah, Z. Zhang, B.S. Snyder, S.D. Rand, T.R. Jensen, D.P. Barboriak and J.L. BoxermanAmerican Journal of Neuroradiology July 2019, 40 (7) 1132-1139; DOI: https://doi.org/10.3174/ajnr.A6110
Pravata, E.
- EDITOR'S CHOICEAdult BrainYou have accessBrain Tumor-Enhancement Visualization and Morphometric Assessment: A Comparison of MPRAGE, SPACE, and VIBE MRI TechniquesL. Danieli, G.C. Riccitelli, D. Distefano, E. Prodi, E. Ventura, A. Cianfoni, A. Kaelin-Lang, M. Reinert and E. PravatàAmerican Journal of Neuroradiology July 2019, 40 (7) 1140-1148; DOI: https://doi.org/10.3174/ajnr.A6096
Fifty-four contrast-enhancing tumors (38 gliomas and 16 metastases) were assessed using MPRAGE, VIBE, and SPACE techniques randomly acquired after gadolinium-based contrast agent administration on a 3T scanner. Enhancement conspicuity was assessed quantitatively by calculating the contrast rate and contrast-to-noise ratio, and qualitatively, by consensus visual comparative ratings. Compared with MPRAGE, both SPACE and VIBE obtained higher contrast rate, contrast-to-noise ratio, and visual conspicuity ratings in both gliomas and metastases. The authors conclude that superior conspicuity for brain tumor enhancement can be achieved using SPACE and VIBE techniques, compared with MPRAGE.
Prodi, E.
- EDITOR'S CHOICEAdult BrainYou have accessBrain Tumor-Enhancement Visualization and Morphometric Assessment: A Comparison of MPRAGE, SPACE, and VIBE MRI TechniquesL. Danieli, G.C. Riccitelli, D. Distefano, E. Prodi, E. Ventura, A. Cianfoni, A. Kaelin-Lang, M. Reinert and E. PravatàAmerican Journal of Neuroradiology July 2019, 40 (7) 1140-1148; DOI: https://doi.org/10.3174/ajnr.A6096
Fifty-four contrast-enhancing tumors (38 gliomas and 16 metastases) were assessed using MPRAGE, VIBE, and SPACE techniques randomly acquired after gadolinium-based contrast agent administration on a 3T scanner. Enhancement conspicuity was assessed quantitatively by calculating the contrast rate and contrast-to-noise ratio, and qualitatively, by consensus visual comparative ratings. Compared with MPRAGE, both SPACE and VIBE obtained higher contrast rate, contrast-to-noise ratio, and visual conspicuity ratings in both gliomas and metastases. The authors conclude that superior conspicuity for brain tumor enhancement can be achieved using SPACE and VIBE techniques, compared with MPRAGE.